We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
(-0.77%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-3.47%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$21.4M |
| 2 |
Stellantis
STLA
|
+$18M |
| 3 |
CNH
CNH Industrial
CNH
|
+$11.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.3M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$23.5M |
| 2 |
Linde
LIN
|
+$8.45M |
| 3 |
Visa
V
|
+$5.42M |
| 4 |
Alcon
ALC
|
+$3.14M |
| 5 |
T-Mobile US
TMUS
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.6% |
| 2 | Technology | 15.24% |
| 3 | Industrials | 9.82% |
| 4 | Financials | 7.82% |
| 5 | Healthcare | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
626
The Gap Inc
GAP
$7.04B
| $4.29K | ﹤0.01% |
+243
| New | +$5.09K |
|
627
Trane Technologies
TT
$105B
| $4.24K | ﹤0.01% |
21
-778
| -97% | -$146K |
|
628
Healthpeak Properties
DOC
$15.4B
| $3.86K | ﹤0.01% |
107
-4,224
| -98% | -$146K |
|
629
Bath & Body Works
BBWI
$4.1B
| $3.63K | ﹤0.01% |
52
| – | – |
|
630
Conagra Brands
CAG
$7.24B
| $3.59K | ﹤0.01% |
105
+57
| +119% | +$1.87K |
|
631
Henry Schein
HSIC
$9.75B
| $3.57K | ﹤0.01% |
46
-5,215
| -99% | -$399K |
|
632
Transocean
RIG
$5.85B
| $3.56K | ﹤0.01% |
1,087
| – | – |
|
633
Knight Transportation
KNX
$11.3B
| $3.54K | ﹤0.01% |
+58
| New | +$3.28K |
|
634
O'Reilly Automotive
ORLY
$75.5B
| $3.53K | ﹤0.01% |
75
-30
| -29% | -$1.3K |
|
|
ACC
635
DELISTED
American Campus Communities, Inc.
ACC
| $3.38K | ﹤0.01% |
+59
| New | +$3.15K |
|
|
CCXI
636
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.35K | ﹤0.01% |
92
-18,314
| -100% | -$643K |
|
637
Dropbox
DBX
$7.16B
| $3.34K | ﹤0.01% |
136
-12,507
| -99% | -$337K |
|
|
638
PUT
Linde
LIN
$235B
| $3.26K | ﹤0.01% |
26
-846
| -97% | -$274K |
|
|
NVO
639
Novo Nordisk
NVO
$219B
| $3.25K | ﹤0.01% |
58
| – | – |
|
640
Keurig Dr Pepper
KDP
$41.1B
| $3.24K | ﹤0.01% |
88
| – | – |
|
641
Columbia Sportswear
COLM
$3.23B
| $3.22K | ﹤0.01% |
33
| – | – |
|
642
Essex Property Trust
ESS
$18.8B
| $3.17K | ﹤0.01% |
9
+6
| +200% | +$2.04K |
|
643
Norwegian Cruise Line
NCLH
$8.95B
| $3.03K | ﹤0.01% |
146
-894
| -86% | -$21.4K |
|
644
Corbus Pharmaceuticals
CRBP
$169M
| $2.93K | ﹤0.01% |
159
| – | – |
|
645
CALL
Interactive Brokers
IBKR
$40.2B
| $2.92K | ﹤0.01% |
+60
| New | +$1.12K |
|
646
Kroger
KR
$35.7B
| $2.85K | ﹤0.01% |
63
+13
| +26% | +$547 |
|
647
Marriott International
MAR
$100B
| $2.64K | ﹤0.01% |
16
-366
| -96% | -$57.6K |
|
648
iShares MSCI Taiwan ETF
EWT
$9.88B
| $2.6K | ﹤0.01% |
39
| – | – |
|
649
Jazz Pharmaceuticals
JAZZ
$16B
| $2.55K | ﹤0.01% |
20
| – | – |
|
650
Cytokinetics
CYTK
$10.9B
| $2.42K | ﹤0.01% |
53
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2021 Portfolio in Review
As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives withdrew a net $14.3M in Q4 2021, closing 247 positions and reducing 309 holdings. Its most notable exit was Visa, an estimated $5.42M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.
Against the trend, Exane Derivatives opened a new position in EngageSmart, Inc. worth $1.1M.
- Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
- Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
- Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
- Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
- Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
- Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
- Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.